Skip to content

High-Intensity Laser Therapy for Eosinophilic Fasciitis

Efficacy of High-Intensity Laser Therapy for the Management of Eosinophilic Fasciitis: A Case Report

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05915585
Enrollment
1
Registered
2023-06-23
Start date
2023-06-18
Completion date
2023-07-20
Last updated
2023-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eosinophilic Fasciitis

Brief summary

Eosinophilic fasciitis (EF) is a rare musculoskeletal disorder characterized by inflammation and thickening of the fascia, leading to pain, stiffness, and functional impairment. Conventional treatment options include immunosuppressive medications, corticosteroids, and physical therapy. This case report will describe use of high-intensity laser therapy (HILT) using the Mectronic Exand MY high-intensity laser system in a patient with EF, highlighting its potential as an alternative or adjunct treatment option.

Interventions

The patient will receive HILT using the Mectronic Exand MY high-intensity laser system with the following parameters: Wavelength: 1064 nm (near-infrared) Power: 12 W Energy density: 8 J/cm² Pulse duration: 200 µs Treatment duration: 10 minutes Frequency: 3 sessions per week for 4 weeks Total energy delivered: 96 J per treatment session

Sponsors

Ahram Canadian University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single participant case study

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with Eosinophilic fasciitis.

Exclusion criteria

* a diagnosis unrelated to Eosinophilic fasciitis

Design outcomes

Primary

MeasureTime frameDescription
Pain intensity via Numeric pain rating scaleChanges in pain intensity at baseline and 4 weeks
Functional outcomes via Disabilities of the Arm, Shoulder and Hand questionnaire (DASH)Changes in DASH at baseline and 4 weeks
Quality of life via Short Form-36 Health SurveyChanges in Short Form-36 Health Survey at baseline and 4 weeks
Adverse event4 Weeksadverse events are recorded by the patient and therapist

Countries

Egypt

Contacts

Primary ContactMohamed M ElMeligie, Ph.d
mohamed.elmeligie@acu.edu.eg+201064442032

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026